Eli Lilly plans to expand insulin access for diabetics, NCD therapies in India

Global pharmaceutical major Eli Lilly, which recently launched its blockbuster anti-obesity drug Mounjaro (tirzepatide) in India, is planning to expand insulin production, collaborate on non-communicable diseases (NCD) therapies, and advanc
Read more...